SEC scrutinises GPs’ role in stake sales

The US regulator is getting to grips with potential conflicts of interest in plain vanilla deals.

31 August 2017•3 mins read
Feature image
LinkedInXEmail

SECONDARIES INVESTOR

Register to unlock this content

  • Daily global secondaries market news and intelligence
  • Curated insights to keep you ahead of GP-led and LP-led secondaries
  • Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
  • Access to proprietary research and reports
  • Selected fund performance and investor activity data
LinkedInXEmail

Related articles